These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3282017)

  • 1. Enzyme-linked immunosorbent assay for human proapolipoprotein A-I using specific antibodies against synthetic peptide.
    Barkia A; Martin C; Puchois P; Gesquiere JC; Cachera C; Tartar A; Fruchart JC
    J Lipid Res; 1988 Jan; 29(1):77-84. PubMed ID: 3282017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human proapoA-ITangier: isolation of proapoA-ITangier and amino acid sequence of the propeptide.
    Brewer HB; Fairwell T; Meng M; Kay L; Ronan R
    Biochem Biophys Res Commun; 1983 Jun; 113(3):934-40. PubMed ID: 6409109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo metabolism of proapolipoprotein A-I in Tangier disease.
    Bojanovski D; Gregg RE; Zech LA; Meng MS; Bishop C; Ronan R; Brewer HB
    J Clin Invest; 1987 Dec; 80(6):1742-7. PubMed ID: 3119665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human proapolipoprotein A-I: development of an antibody to the propeptide as a probe of apolipoprotein A-I biosynthesis and processing.
    Hospattankar AV; Fairwell T; Appella E; Meng M; Brewer HB
    Biochem Biophys Res Commun; 1987 Nov; 149(1):289-96. PubMed ID: 3120726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proapolipoprotein A-I conversion kinetics in vivo in human and in rat.
    Ghiselli G; Gotto AM; Tanenbaum S; Sherrill BC
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):874-8. PubMed ID: 3919384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasma proapoA-I: isolation and amino-terminal sequence.
    Brewer HB; Fairwell T; Kay L; Meng M; Ronan R; Law S; Light JA
    Biochem Biophys Res Commun; 1983 Jun; 113(2):626-32. PubMed ID: 6409108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human apolipoprotein A-I isoprotein metabolism: proapoA-I conversion to mature apoA-I.
    Bojanovski D; Gregg RE; Ghiselli G; Schaefer EJ; Light JA; Brewer HB
    J Lipid Res; 1985 Feb; 26(2):185-93. PubMed ID: 3989377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I.
    Batal R; Tremblay M; Krimbou L; Mamer O; Davignon J; Genest J; Cohn JS
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):655-64. PubMed ID: 9555873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of proapoa-I in rat lymph and plasma: metabolic conversion to "mature" apoA-I.
    Ghiselli G; Bradley WA; Gotto AM; Sherrill BC
    Biochem Biophys Res Commun; 1983 Oct; 116(2):704-11. PubMed ID: 6418165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative determination of human plasma apolipoprotein A-I by a noncompetitive enzyme-linked immunosorbent assay.
    Koren E; Puchois P; McConathy WJ; Fesmire JD; Alaupovic P
    Clin Chim Acta; 1985 Apr; 147(2):85-95. PubMed ID: 3921293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High yield overexpression and characterization of human recombinant proapolipoprotein A-I.
    McGuire KA; Davidson WS; Jonas A
    J Lipid Res; 1996 Jul; 37(7):1519-28. PubMed ID: 8827524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction.
    Huang W; Sasaki J; Matsunaga A; Han H; Li W; Koga T; Kugi M; Ando S; Arakawa K
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):210-6. PubMed ID: 10634820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of apolipoprotein A-I concentration in nonhuman primate serum by enzyme-linked immunosorbent assay (ELISA).
    Koritnik DL; Rudel LL
    J Lipid Res; 1983 Dec; 24(12):1639-45. PubMed ID: 6421975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.
    Schmitz G; Assmann G; Rall SC; Mahley RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6081-5. PubMed ID: 6412234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of human plasma apolipoprotein A-II by a non competitive enzyme-linked immunosorbent assay.
    Puchois P; Kandoussi A; Duriez P; Fruchart JC; McConathy WJ; Koren E
    J Immunoassay; 1986; 7(4):285-307. PubMed ID: 3100579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein.
    Huang W; Matsunaga A; Li W; Han H; Hoang A; Kugi M; Koga T; Sviridov D; Fidge N; Sasaki J
    Atherosclerosis; 2001 Nov; 159(1):85-91. PubMed ID: 11689210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies specific for different regions of human apolipoprotein A-I. Characterization of an antibody that does not bind to a genetic variant of apoA-I (Glu----136 Lys).
    Ehnholm C; Lukka M; Rostedt I; Harper K
    J Lipid Res; 1986 Dec; 27(12):1259-64. PubMed ID: 2435827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the propeptide of apolipoprotein A-I impairs exit of nascent apolipoprotein A-I from the endoplasmic reticulum.
    McLeod RS; Robbins C; Burns A; Yao Z; Pritchard PH
    Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):641-8. PubMed ID: 7945187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing of proapolipoprotein AI requires specific conformation.
    Stoffel W; Niedel B
    Biol Chem Hoppe Seyler; 1985 Feb; 366(2):181-7. PubMed ID: 3921042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of human serum apolipoprotein AI by enzyme immunoassay.
    Bury J; Rosseneu M
    Clin Chem; 1985 Feb; 31(2):247-51. PubMed ID: 3917876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.